OR4F4 Antibody

What is OR4F4 and what is its biological significance?

OR4F4 (Olfactory Receptor Family 4 Subfamily F Member 4) is a member of the G-protein-coupled receptor (GPCR) family involved in olfactory sensation. Olfactory receptors interact with odorant molecules in the nose to initiate neuronal responses that trigger smell perception . These receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals . Interestingly, the olfactory receptor gene family is the largest in the human genome, with OR4F4 being one of its members located on chromosome 15 . The protein functions primarily as a cell membrane-bound multi-pass receptor with a calculated molecular weight of approximately 34 kDa .

What types of OR4F4 antibodies are available for research?

Most commercially available OR4F4 antibodies are rabbit polyclonal antibodies . These antibodies are typically generated against synthetic peptides derived from the C-terminal region of human OR4F4, often corresponding to amino acids 256-305 . Some antibodies are designed to recognize multiple related proteins including OR4F4, OR4F5, and OR4F17, which have similar structures and functions . These cross-reactive antibodies are particularly useful for studies investigating the broader olfactory receptor family rather than a single specific member.

How are OR4F4 antibodies typically validated for research use?

OR4F4 antibodies undergo validation through several complementary techniques:

• Western Blot (WB): Verifies specificity by confirming the predicted molecular weight (~34 kDa)

• Immunofluorescence/Immunocytochemistry (IF/ICC): Confirms proper subcellular localization, primarily in the cell membrane

• ELISA: Tests binding efficiency to the target antigen

• Cross-reactivity testing: Evaluates specificity across different species (human, mouse, rat)

Validation data typically includes positive and negative control cell lines or tissues to ensure that the observed signals are specifically associated with OR4F4 expression patterns .

What are the optimal conditions for using OR4F4 antibodies in Western Blot experiments?

For Western Blot applications, the following protocol is generally recommended:

Sample preparation:

• Use standard protein extraction methods that preserve membrane proteins

• Include protease inhibitors to prevent degradation

• Denature samples thoroughly as OR4F4 is a multi-pass membrane protein

Recommended protocol:

• Use 1:500-1:2000 dilution of the primary antibody

• Incubate overnight at 4°C for optimal binding

• Use appropriate secondary antibodies (typically anti-rabbit IgG conjugated with HRP)

• The expected molecular weight is approximately 34 kDa, though post-translational modifications may alter migration patterns

It's important to note that membrane proteins like OR4F4 may require special consideration during sample preparation, including sufficient denaturation to expose epitopes that might be hidden within membrane-spanning domains .

How should OR4F4 antibodies be used for immunofluorescence applications?

For immunofluorescence and immunocytochemistry applications:

Sample preparation:

• Fixation methods may influence epitope accessibility; paraformaldehyde (4%) is commonly used

• Permeabilization is critical since OR4F4 has intracellular epitopes

Recommended protocol:

• Use antibody at 1:100-1:500 dilution

• Include appropriate blocking to reduce background

• Incubate with primary antibody for 1-3 hours at room temperature or overnight at 4°C

• Use fluorophore-conjugated secondary antibodies (e.g., anti-rabbit IgG coupled with FITC or similar fluorophores)

• Counterstain nuclei with DAPI for orientation

Positive staining should appear predominantly at the cell membrane, consistent with OR4F4's biological location as a transmembrane protein .

What cell lines or tissue types are most appropriate for studying OR4F4 expression?

Based on the biological function of OR4F4:

• Olfactory epithelium: Primary tissue for physiologically relevant expression

• Cell lines: Several human cell lines have been used successfully, including:

  • A549 cells (demonstrated in immunofluorescence applications)

  • Human cell lines of neuronal origin

When selecting control tissues or cell lines, it's important to consider that olfactory receptors can have varying expression patterns, and some may be expressed extraneously outside the olfactory system .

How can cross-reactivity with other olfactory receptors be addressed in OR4F4 antibody experiments?

Cross-reactivity is a significant consideration when working with olfactory receptor antibodies:

• Verify specificity: Some antibodies specifically cross-react with related receptors OR4F5 and OR4F17 by design

• Validation strategies:

  • Use knockout/knockdown controls where possible

  • Compare results with multiple antibodies raised against different epitopes

  • Perform peptide competition assays to confirm specificity

  • Conduct parallel experiments with transcript-level detection (RT-PCR, RNA-seq)

For researchers needing absolute specificity to OR4F4 alone (as opposed to OR4F5 and OR4F17), carefully review the product information to ensure the antibody doesn't have known cross-reactivity with other family members .

What are the main technical challenges when working with OR4F4 antibodies?

Several technical challenges are common when working with antibodies against membrane proteins like OR4F4:

• Epitope accessibility: The seven-transmembrane structure may limit access to certain epitopes

• Background signals: Due to the extensive family of related receptors, non-specific binding can occur

• Protein denaturation: Complete denaturation is crucial for Western blot but may destroy conformational epitopes

• Fixation artifacts: Over-fixation can mask epitopes in ICC/IF applications

To address these challenges:

• Optimize protein extraction methods for membrane proteins

• Test multiple antibody concentrations and incubation conditions

• Include appropriate blocking steps to reduce background

• Consider native vs. denaturing conditions based on experimental needs

How can contradictory results between different detection methods be resolved?

When facing contradictory results:

• Analyze experimental conditions: Different methods expose different epitopes

  • Western blot detects denatured proteins

  • IF/ICC may detect native conformations

• Consider technical approach:

  • Verify antibody lot consistency

  • Test multiple antibodies targeting different epitopes

  • Compare with mRNA expression data (qPCR, RNA-seq)

  • Use mass spectrometry for independent validation

• Biological context:

  • Protein expression may vary by cell state or experimental conditions

  • Post-translational modifications may affect antibody binding

  • Protein localization can change under different conditions

How can OR4F4 antibodies be used to investigate olfactory receptor trafficking?

To study OR4F4 trafficking:

• Live-cell imaging: Combine OR4F4 antibodies with trafficking markers in unfixed cells

• Subcellular fractionation: Use Western blot to detect OR4F4 in different cellular compartments

• Co-localization studies:

  • Pair OR4F4 antibodies with markers for:

    • Endoplasmic reticulum (e.g., calnexin)

    • Golgi apparatus (e.g., GM130)

    • Plasma membrane (e.g., Na+/K+ ATPase)

    • Endosomal compartments (e.g., Rab proteins)

These approaches can reveal how OR4F4 moves from synthesis to functional localization at the cell membrane and how this trafficking might be regulated under different conditions .

What considerations should be made when designing experiments to study OR4F4 interactions with other proteins?

For protein interaction studies:

• Co-immunoprecipitation (Co-IP):

  • Use OR4F4 antibodies for pull-down experiments

  • Consider epitope accessibility in native conditions

  • Use gentle detergents to maintain protein-protein interactions

  • Verify reciprocal Co-IP with antibodies against potential interacting partners

• Proximity ligation assays:

  • Combine OR4F4 antibodies with antibodies against potential interacting partners

  • Optimize fixation to preserve both proteins and their interactions

• Controls:

  • Include negative controls (non-relevant antibodies of the same isotype)

  • Use competing peptides to verify specificity

  • Consider potential cross-linking artifacts in fixed samples

What are the methodological considerations for studying OR4F4 in heterologous expression systems?

When expressing OR4F4 in heterologous systems:

• Expression optimization:

  • Consider codon optimization for the host system

  • Include trafficking enhancers (e.g., N-terminal rhodopsin tags) to improve surface expression

  • Use inducible expression systems to control expression levels

• Detection strategies:

  • Compare endogenous vs. overexpressed protein size and localization

  • If using tagged constructs, verify that the tag doesn't interfere with antibody binding

  • Consider dual detection with both tag-specific and OR4F4-specific antibodies

• Functional assays:

  • Verify that the expressed protein retains functional properties

  • Consider calcium imaging or cAMP assays to test receptor activation

  • Combine with trafficking studies to ensure proper membrane localization

What are the current limitations in our understanding of OR4F4 biology that could be addressed with improved antibody-based approaches?

Current knowledge gaps that could be addressed include:

• Tissue distribution:

  • Systematic immunohistochemistry across tissues to identify unexpected expression sites

  • Single-cell approaches to identify specific cell types expressing OR4F4

• Signaling pathways:

  • Phospho-specific antibodies to track activation states

  • Temporal studies of downstream signaling activation

• Structural biology:

  • Conformation-specific antibodies to capture different receptor states

  • Using antibodies to stabilize protein for structural studies

• Ligand binding and activation:

  • Competitive binding assays with potential ligands

  • Correlation between ligand binding and receptor conformational changes

OR4F4 Antibody Specifications Comparison Table

OR4F4 Protein Characteristics Table